Cargando…
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases
Osteoprotegerin (OPG) is a glycoprotein involved in the regulation of bone remodelling. OPG regulates osteoclast activity by blocking the interaction between the receptor activator of nuclear factor kappa B (RANK) and its ligand (RANKL). More and more studies confirm the relationship between OPG and...
Autores principales: | Dutka, Mieczysław, Bobiński, Rafał, Wojakowski, Wojciech, Francuz, Tomasz, Pająk, Celina, Zimmer, Karolina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197867/ https://www.ncbi.nlm.nih.gov/pubmed/34313900 http://dx.doi.org/10.1007/s10741-021-10153-2 |
Ejemplares similares
-
Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children
por: Wasilewska, Anna, et al.
Publicado: (2010) -
Targeting the RANKL/RANK/OPG Axis for Cancer Therapy
por: Ming, Jie, et al.
Publicado: (2020) -
Biology of RANK, RANKL, and osteoprotegerin
por: Boyce, Brendan F, et al.
Publicado: (2007) -
Dysregulation of the RANKL/RANK/OPG axis in thalassemia intermedia patients
por: Alfaqih, Mahmoud A., et al.
Publicado: (2018) -
Rank-Rankl-Opg Axis in Multiple Sclerosis: The Contribution of Placenta
por: Passaponti, Sofia, et al.
Publicado: (2022)